Prostate cancer in transgender women: A propensity score–matched analysis of disease severity and survival
Cancer · 2024
DOI: 10.1002/cncr.35469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Margaret Meagher und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of California San Diego School of Medicine, La Jolla, California, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Transgender Persons, Propensity Score, SEER Program. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Department of Defense, Padres Pedal the Cause.
Abstract (Originalsprache)
Background
Despite the rise in gender‐affirming care, our understanding of prostate cancer (PCa) in transgender women (TGW) remains in its infancy. Health disparities and lack of PCa awareness and screening are possible barriers to providing quality care for this population. In addition, the implication of hormonal manipulation for the aggressiveness of PCa in TGW is yet to be determined. Here, this study sought to compare oncological characteristics and survival outcomes between transgender and cisgender (CG) patients with PCa via two national data sets.
Methods
The Veterans Affairs Informatics and Computing Infrastructure database (1999–2020) and the Surveillance, Epidemiology, and End Results–Medicare database (2010–2017) were reviewed. Demographic and clinical details were analyzed. Logistic regression analysis was performed on propensity score–matched groups to identify predictors of high‐risk disease and metastasis in patients with PCa. Groups were matched 5:1 (CG:TGW) on the basis of age, race, year of diagnosis, and Charlson Comorbidity Index score. Primary outcomes included metastatic presentation, high‐risk localized disease, overall survival (OS), and prostate cancer–specific mortality (PCSM).
Results
A total of 1194 patients were included (199 TGW; 995 CG). Associations between transgender identity and metastatic presentation (odds ratio [OR], 0.38; p = .2), high‐risk localized disease (OR, 1.19; p = .50), or PCSM (hazard ratio [HR], 0.65; p = .3) were not detected. Transgender identity was associated with improved OS (HR, 0.67; p = .014).
Conclusions
PCa‐specific outcomes seem comparable between TGW and CG men, although the study was underpowered to detect modest differences. Further investigation into the incidence and outcomes of PCa in TGW is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of California San Diego School of Medicine, La Jolla, California, USA.
- Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, USA.
- Veterans Affairs Hospital San Diego, San Diego, California, USA.
- Center of Health Equity Education and Research, University of San Diego, La Jolla, California, USA.
- Departments of Medicine and Family Medicine, University of California San Diego School of Medicine, La Jolla, California, USA.
- Department of Urology, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Stephen Freedland, Amirali Salmasi
Förderung
- Department of Defense
- Padres Pedal the Cause
Zitieren
APA
Meagher, M., Morgan, K., Deshler, L., Riviere, P., Dolendo, I., Rose, B., Jamieson, C., Morris, S., Nik-Ahd, F., Freedland, S., Anger, J., & Salmasi, A. (2024). Prostate cancer in transgender women: A propensity score–matched analysis of disease severity and survival. Cancer. https://doi.org/10.1002/cncr.35469
Vancouver
Meagher M, Morgan K, Deshler L, Riviere P, Dolendo I, Rose B, et al. Prostate cancer in transgender women: A propensity score–matched analysis of disease severity and survival. Cancer. 2024. doi:10.1002/cncr.35469
BibTeX
@article{Meagher2024,
author = {Meagher, Margaret and Morgan, Kylie and Deshler, Leah and Riviere, Paul and Dolendo, Isabella and Rose, Brent and Jamieson, Christina and Morris, Sheldon and Nik-Ahd, Farnoosh and Freedland, Stephen and Anger, Jennifer and Salmasi, Amirali},
title = {Prostate cancer in transgender women: A propensity score–matched analysis of disease severity and survival},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35469}
}
EUVIMED